X
PROVENGE. Powerfully Personal.
PROVENGE is the only individualized immunotherapy for advanced prostate cancer.
Therapy can be completed in a little over a month with only 6 appointments
The most common side effects in clinical studies were chills, fatigue, fever, back pain, nausea, joint ache, and headache. Some men have experienced serious adverse events. See Important Safety Information
PROVENGE has been prescribed to over 30,000 men
PROVENGE immunotherapy is different from other prostate cancer treatments because it can activate your own immune system to seek out and attack your advanced prostate cancer. PROVENGE immunotherapy helps certain men with mCRPC who do not take prescription medicine for cancer-related pain live longer and treatment takes only about 1 month. Activate the PROVENGE difference.
Cutting-edge treatments are available for every stage of prostate cancer. Learn how routine monitoring can help you take control of your prostate cancer fight so that you get the best out of treatment at every step of your journey.
There are many ways to connect with the large community of men undergoing a similar journey to yours. Start the PROVENGE conversation by using the doctor locator to find a treatment center near you and explore available resources, from community support groups to financial assistance.
PROVENGE is a personalized immunotherapy. PROVENGE activates your immune system to seek out and attack your advanced prostate cancer.
PROVENGE® (sipuleucel-T) is a prescription medicine that is used to treat certain patients with advanced prostate cancer. PROVENGE is made from your own immune cells.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information.
You are now leaving Provenge.com. We are not responsible for content on the third party web site to which you will be going. Please review our web site Legal Notice and Privacy Policy.
Access this brochure to learn about PROVENGE and how it may help certain men with advanced prostate cancer (mCRPC) live longer.